This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Enliven Therapeutics, Inc. (Enliven or the Company) , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced positive ...

Something like, for instance, a surprise Witcher 3 DLC. Chrzanowski predicted that a new expansion would ring up roughly $330 ...

Flu activity is surging and expected to continue. Meanwhile, the Florida Health Department hasn't released a weekly report in ...

A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.

Increased use of organoids in cancer research: The Würzburg lighthouse project "Preclinical Models" is working towards this ...

Blood vessel changes in the eye mirror brain damage in mice with a gene variant linked to dementia, potentially offering ...

As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...

Rare cat breeds often serve as luxury status symbols, with kittens fetching $1,000 to $6,000 upfront from reputable breeders.

A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia. The findings offer insight into why some people are ...

Breakthrough Therapy Designation granted to zoldonrasib for the treatment of adult patients with KRAS G12D-mutated locally ...

Revolution Medicines shares jump nearly 29% to a record high after a WSJ report said AbbVie showed takeover interest, a claim the pharma giant later denied.